Candesartan cilexetil
NDC 70771-1205, Candesartan cilexetil, tablet, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1205
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091390
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1205 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANDESARTAN CILEXETIL8 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1205-3 | 70771120503 | 30 TABLET in 1 BOTTLE (70771-1205-3) |
| 70771-1205-9 | 70771120509 | 90 TABLET in 1 BOTTLE (70771-1205-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/26df3269-3682-4ce0-be81-8c029254b5a8
Use it
Look up 70771-1205 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1205 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1205. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.